Search results
Inverted Tulip Deformation
Author(s):
Kevin Velarde-Acosta
,
Josh Yefry Moscoso Ramirez
,
Paol Jhullian Rojas
,
et al
Added:
4 months ago
Article
Author(s):
Christopher R Ellis
Added:
1 year ago
AF Symposium 2024 – In this interview, Dr Christopher R Ellis (Vanderbilt University Medical Center, US) joins us to discuss the early findings from the EMERGE LAA Post-Approval Study.The study investigated the early postapproval outcomes of the Amulet occluder device within the United States, using data from the Left Atrial Appendage Occlusion Registry.Questions:What is the background of this…
View more
Author(s):
Arpanjeet Kaur
,
Yash Patel
,
Jacqueline Tamis-Holland
Added:
1 year ago
Author(s):
Josep Rodés-Cabau
Added:
1 month ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device…
View more
Author(s):
Mayra Guerrero
Added:
1 month ago
Gain essential insights into the pivotal trials and procedural techniques shaping transcatheter mitral valve replacement with Dr Mayra GuerreroThis presentation, part of Women As One's comprehensive Structural Interventions track, provides timely analysis of the landmark SUMMIT and ENCIRCLE trials that are defining the future of dedicated mitral devices.Drawing from clinical trial data showing…
View more
Author(s):
Ignacio Inglessis-Azuaje
Added:
1 month ago
Navigate the complexities of patient selection and device matching in TMVR with Dr Ignacio Inglessis-AzuajeThis presentation, part of Women As One's comprehensive Structural Interventions track, provides essential guidance for clinicians approaching this rapidly evolving field. The presentation systematically explores general eligibility requirements including symptomatic severity, surgical risk…
View more
Author(s):
Yoel Benarroch
,
Natalie Tapaskar
,
Amin Yehya
Added:
2 months ago
Author(s):
Dhanunjaya Lakkireddy
Added:
1 year ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE …
View more
Author(s):
Nir Uriel
Added:
1 month ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation…
View more
Added:
4 months ago
US Cardiology Review 2025;19:e14.
View more